Dilated cardiomyopathy (DCM) is a leading cause of nonischemic heart failure. Genetic causes are identifiable in 25% to 30% of patients. This review describes the pathophysiology underlying genetic DCM, the genes most strongly associated with DCM, and both standard and novel therapies for treating genetic DCM.
Genetic Dilated Cardiomyopathy: A Review / Boslough, M., Taylor, M.R.G., Mestroni, L., Lombardi, R.. - In: METHODIST DEBAKEY CARDIOVASCULAR JOURNAL. - ISSN 1943-3344. - 22:4(2026), pp. 68-77. [10.14797/mdcvj.1849]
Genetic Dilated Cardiomyopathy: A Review
Lombardi, Raffaella
Ultimo
Supervision
2026
Abstract
Dilated cardiomyopathy (DCM) is a leading cause of nonischemic heart failure. Genetic causes are identifiable in 25% to 30% of patients. This review describes the pathophysiology underlying genetic DCM, the genes most strongly associated with DCM, and both standard and novel therapies for treating genetic DCM.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
